Archived Newsletters

  1. 04.03.26 -- What If The U.S. Government Stopped Funding Biotech? 4/3/2026
    04/03/26 Outsourced Pharma Newsletter
  2. 04.02.26 -- Does Biotech Need More (Government) Funding — Or A New Growth Model? 4/2/2026
    04/02/26 Outsourced Pharma Newsletter
  3. 04.01.26 -- The Long Road To U.S. Vaccine Manufacturing 4/1/2026
    04/01/26 Outsourced Pharma Newsletter
  4. 03.31.26 -- Watch: 60 Seconds on Atypical Optimization + More 3/31/2026

    03/31/26 Outsourced Pharma Newsletter

  5. 03.31.26 -- The Jones Act Hurts U.S. Pharmaceutical Manufacturing 3/31/2026
    03/31/26 Outsourced Pharma Newsletter
  6. 03.30.26 -- STREAM Insights Driving Innovation Across Pharma Development 3/30/2026
    03/30/26 Outsourced Pharma Newsletter
  7. 03.30.26 -- What If The U.S. Government Stopped Funding Biotech? 3/30/2026
    03/30/26 Outsourced Pharma Newsletter
  8. 03.27.26 -- Advising The Biotech C-Suite To Reconsider Quality 3/27/2026
    03/27/26 Outsourced Pharma Newsletter
  9. 03.26.26 -- The Hidden Obstacles Stalling Advanced Therapies 3/26/2026

    03/26/26 Outsourced Pharma Newsletter

  10. 03.26.26 -- A simple, helpful look at PUPSIT implementation. 3/26/2026

    03/26/26 Outsourced Pharma Newsletter